(Q37773637)

22 August 2017

1 reference

title

Can the nephrologist prevent dialysis-related amyloidosis? (English)

1 reference

22 August 2017

0 references

Zingraff J

1

1 reference

22 August 2017

Drüeke T

series ordinal

2

1 reference

22 August 2017

language of work or name

1 reference

1 July 1991

1 reference

American Journal of Kidney Diseases

22 August 2017

1 reference

22 August 2017

18

1 reference

22 August 2017

1

1 reference

22 August 2017

1-11

1 reference

A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Beta-2 microglobulin is an amyloidogenic protein in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Lysine-specific cleavage of beta 2-microglobulin in amyloid deposits associated with hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Synovial amyloidosis in patients undergoing long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Hemodialysis-associated amyloidosis and beta-2 microglobulin. Clinical and immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Chronic renal failure treatment duration and mode: their relevance to the late dialysis periarticular syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Beta 2-microglobulin amyloidosis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Plasma β2, Microglobulin Turnover in Renal Insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Alpha- and gamma-interferon (IFN alpha, IFN gamma) but not interleukin-1 (IL-1) modulate synthesis and secretion of beta 2-microglobulin by hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Beta 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

A bone-derived growth factor isolated from rat calvariae is beta 2 microglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Beta 2-microglobulin is not a bone cell mitogen

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Inhibitory effects of beta 2-microglobulin on in vitro calcification of osteoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Collagen-binding affinity of beta-2-microglobulin, a preprotein of hemodialysis-associated amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Autocrine induction of collagenase by serum amyloid A-like and beta 2-microglobulin-like proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Thymotaxin, a chemotactic protein, is identical to beta 2-microglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

In vitro formation of amyloid fibrils from intact beta 2-microglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Serum beta2-microglobulin in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Haemodialysis membranes, serum beta 2-microglobulin, and dialysis amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Permeability and secondary membrane formation of a high flux polysulfone hemofilter

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Different handling of beta 2-microglobulin during hemodialysis and hemofiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Removal, generation and adsorption of beta-2-microglobulin during hemofiltration with five different membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Kinetic and clinical studies of beta 2-microglobulin in continuous ambulatory peritoneal dialysis: influence of renal and enhanced peritoneal clearances using glucose polymer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Clearance of beta-2-microglobulin using continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Turnover in humans of β2-microglobulin: the constant chain of HLA-antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Complement Activation and Hypersensitivity Reactions to Dialysis Membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Effects of complement activation by hemodialysis membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

No change in corrected beta 2-microglobulin concentration after cuprophane haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Effects of dialysis membranes on beta 2-microglobulin production and cellular expression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Microbial and endotoxin contamination in water and dialysate in the central United States

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Beta-2-microglobulin and main granulocyte components in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Increase of C-reactive protein serum values following haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Generation and removal of anaphylatoxins during hemofiltration with five different membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. I. Radiolabeled endotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Induction of IL-1 during hemodialysis: Transmembrane passage of intact endotoxins (LPS)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Amyloid syndromes associated with hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Carpal tunnel syndrome and type of dialysis membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Case control study on dialysis arthropathy: the influence of two different dialysis membranes: data from the EDTA Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Rheumatic syndromes and beta 2-microglobulin amyloidosis in patients receiving long-term peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Interleukin-1 and the Pathogenesis of the Acute-Phase Response

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Creation of "Amyloid" Fibrils from Bence Jones Proteins in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Dialysis arthropathy: amyloid or iron?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Aluminum and dialysis arthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Effect of aluminium on superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Erosive azotemic osteoarthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Hemodialysis is not essential for the development of destructive spondylarthropathy in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Erosive Spondyloarthropathy in Long-Term Dialysis Patients: Relationship to Severe Hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Specific imaging of dialysis-related amyloid deposits using 131I-beta-2-microglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

New frontiers in the study of amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Radionuclide exploration of dialysis amyloidosis: preliminary experience

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Pseudotumor of the craniocervical junction during long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Endoscopic management of shoulder pain in long-term haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

Renal transplantation for dialysis arthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980283-6

7 January 2021

10.1016/S0272-6386(12)80283-6

Identifiers

DOI

1 reference

release_ovesziafabfvvle2jqjqde5wpu

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ovesziafabfvvle2jqjqde5wpu

24 November 2022

mapped directly with Wikidata item

1 reference